Primary packaging, secondary packaging and labeling, and pre-filled syringe assembly solutions and services
Ensuring investigational medicinal product (IMP) integrity, advancing medication adherence, and avoiding delays in trial timelines are all top of mind for biotechnology and pharmaceutical companies embarking on the clinical trial journey.
Thermo Fisher Scientific pharma services offer global clinical packaging capabilities — which include fully-owned cGMP facilities, patient-centric packaging solutions, and efficient processes and time saving tools — to help prevent potential holdups along the way.
Our facilities support ambient, refrigerated, and frozen packaging capabilities, and are strategically located around the globe to accommodate regional needs. An integrated IT system links the facilities to give clients control over inventory via bar code standards.
Our latest innovation in clinical packaging: The tamper evident carton, designed to meet the needs of today’s biotech and biopharma markets. Patented in 2024, this solution features a protective carton design and tamper-evident sealing to ensure the safety of your vials.
Smart packaging uses microcircuits to passively measure dosing data and connects to the cloud through technology such as the patient’s smartphone. Cloud-based platforms then use sophisticated algorithms to analyze patient dosing behaviors and flag anything erratic, so site staff can “rescue” patients and get them back on their appropriate regimen.
Smart packaging for medication adherence provides a rich and reliable data set to help better understand patient dosing — making it applicable to most clinical trial designs. It’s especially useful for clinical trials that: